Treatment of Secondary Pulmonary Hypertension with Bosentan after Left Ventricular Assist Device Implantation

E-ISSN： 1755-5922|33|2|50-55

ISSN： 1755-5914

Source： CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.2, 2015-04, pp. : 50-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Right ventricular failure after implantation of continuous flow left ventricular assist device: analysis of predictors and outcomes

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 9, 2015-09 ,pp. : 763-770

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implantation of a Jarvik 2000 left ventricular assist device as a bridge to eligibility for refractory heart failure with renal dysfunction

By Kainuma Satoshi

Journal of Artificial Organs, Vol. 15, Iss. 1, 2012-03 ,pp. : 83-86

Springer Publishing Company

Access to resources Recommend Favorite

Prothrombin complex concentrate for factor VII replacement in a patient undergoing left ventricular assist device implantation with factor VII deficiency

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E185-E185

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bosentan for treatment of pulmonary arterial hypertension (I)

By Antoniu Sabina A

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 843-847

Future Medicine

Access to resources Recommend Favorite

Bosentan for the treatment of pulmonary arterial hypertension (II)

By Antoniu Sabina A

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 849-852

Future Medicine

Access to resources Recommend Favorite